PLENVU- polyethylene glycol 3350, sodium sulfate, sodium chloride, potassium chloride, ascorbic acid, sodium ascorbate kit Spojené štáty - angličtina - NLM (National Library of Medicine)

plenvu- polyethylene glycol 3350, sodium sulfate, sodium chloride, potassium chloride, ascorbic acid, sodium ascorbate kit

salix pharmaceuticals, inc - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium sulfate (unii: 0ypr65r21j) (sodium sulfate anhydrous - unii:36kcs0r750), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - plenvu® is indicated for cleansing of the colon in preparation for colonoscopy in adults. plenvu is contraindicated in the following conditions: risk summary there are no available data with plenvu in pregnant women to inform a drug-associated risk for adverse developmental outcomes. animal reproduction studies have not been conducted with plenvu. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. risk summary there are no data available to assess the presence of plenvu in human milk, the effects on the breastfed child or the effects on milk production. the lack of clinical data during lactation precludes a clear determination of the risk of plenvu to a child during lactation; therefore

Sodium Chloride 0.9% w/v and Glucose 5% w/v Solution for Infusion BP Malta - angličtina - Malta Medicines Authority

sodium chloride 0.9% w/v and glucose 5% w/v solution for infusion bp

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - sodium chloride, glucose - solution for infusion - sodium chloride 9.0 g/l glucose 50 g/l - blood substitutes and perfusion solutions

SODIUM CHLORIDE 0.3% AND GLUCOSE 3.3% SOLUTION FOR INFUSION BAXTER Izrael - angličtina - Ministry of Health

sodium chloride 0.3% and glucose 3.3% solution for infusion baxter

teva israel ltd - glucose as monohydrate; sodium chloride - solution for infusion - glucose as monohydrate 33 g/l; sodium chloride 3 g/l - electrolytes with carbohydrates - a source of water supply, electrolytes and calories

SODIUM CHLORIDE AND GLUCOSE 0.9/5.0 %w/v Solution for Infusion Írsko - angličtina - HPRA (Health Products Regulatory Authority)

sodium chloride and glucose 0.9/5.0 %w/v solution for infusion

baxter healthcare limited - sodium chloride glucose - solution for infusion - 0.9/5.0 %w/v

Sodium Chloride Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

sodium chloride

baxter healthcare ltd - sodium chloride 0.45% - solution for infusion - 0.45 % - active: sodium chloride 0.45% - hypotonic sodium chloride (0.45%) intravenous infusion is mainly used as a hydrating agent solution.

Sodium Chloride Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

sodium chloride

baxter healthcare ltd - sodium chloride 3% - solution for infusion - 3 % - active: sodium chloride 3% - hypertonic sodium chloride (3%) intravenous infusion is used in the management of severe sodium chloride depletion when electrolyte restoration is required.

Dianeal PD4 Glucose 1.36% w/v 13.6mg/ml Malta - angličtina - Malta Medicines Authority

dianeal pd4 glucose 1.36% w/v 13.6mg/ml

baxter healthcare limited - calcium chloride; anhydrous glucose; magnesium chloride anhydrous; sodium chloride; sodium lactate - solution for peritoneal dialysis - calcium chloride 0.0184 % (w/v); anhydrous glucose 1.36 % (w/v); magnesium chloride anhydrous 0.0051 % (w/v); sodium chloride 0.538 % (w/v); sodium lactate 0.448 % (w/v) - blood substitutes and perfusion solutions